Dr. Jessica Hope Ballou, MD

Dr. Ballou practices at Vanderbilt Medical Group in Nashville, Tennessee.

Dr. Ballou's NPI, 1588082788, was assigned on April 3, 2014. Dr. Ballou graduated from University of Texas Southwestern Medical School at Dallas in 2014. Dr. Ballou holds Tennessee license 71456.

Dr. Ballou's primary practice is Vanderbilt Medical Group, at 3841 Green Hills Village Dr, Nashville, TN 37215 in Davidson County. The practice phone is (615) 936-2000.

Dr. Ballou's primary practice is Vanderbilt Medical Group in Nashville, Tennessee. Dr. Ballou is also affiliated with Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Ballou to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ballou practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Ballou's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dmand AI has Dr. Ballou's licenses on file in 2 states: Tennessee and Oregon.

CMS data shows 12 Medicare services from Dr. Ballou across 1 procedure code in 2024, for 28 Medicare patients. Medicare paid $1,052 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 28 Medicare patients who saw Dr. Ballou in 2024. The largest group is 75 to 84, with 11 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ballou's median patient age at 57, with 48% women.

In 2024, Dr. Ballou wrote 14 Medicare Part D claims. 93% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $67 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Ballou for performance year 2024, reported through an alternative payment model (APM). Dr. Ballou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of removal of tissue by Dr. Ballou, more than 68% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Ballou, published from 2018 to 2023. 2019 was the busiest year, with 2. The most frequent topics are Palliative Care, Curriculum and Intensive Care Units. Dr. Ballou has published most often in J Trauma Acute Care Surg. Dr. Ballou's most frequent co-authors are Karen J. Brasel, MD, Saman Arbabi, MD and Sasha D. Adams, MD.

CMS Open Payments shows 25 general payments to Dr. Ballou from 11 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Integra LifeSciences Corporation paid the most, $897.

Dr. Ballou graduated from University of Texas Southwestern Medical School at Dallas in 2014.